VVOS
#4935
Vivos Therapeutics, Inc. - Common Stock
0.2 6 USD
+0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+4.00%
Monthly Change
-40.91%
6 month change
-80.74%
Year Change
-94.47%
Previous Close
0.2 5
Open
0.2 6
Low
0.2 6
High
0.2 6
Volume
3
Financials
- Market Capitalization 5.23 M
- Employee 268
- Founded 2016
- CEO N/A
- Website www.vivos.com
- Headquarter Delaware, United States
- FIGI BBG00H1NZV76
- Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.98
Price to sales ratio
1.2
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4923 |  XAIR Beyond Air, Inc. - Common Stock | 5.70 USD | +14.69% | +7.55% | +4.40% | +163.89% | 5.46 M USD | ||
| 4924 |  ITOC iTonic Holdings Ltd - Class A Ordinary Shares | 0.32 USD | +10.34% | +6.67% | +14.29% | -64.44% | 5.46 M USD | ||
| 4978 |  OSRH OSR Holdings, Inc. - Common Stock | 0.12 USD | 0.00% | -60.00% | -73.91% | -71.66% | 4.21 M USD | ||
| 4984 |  FEED ENvue Medical, Inc. - Common Stock | 0.37 USD | -2.63% | -7.50% | +8.82% | -91.99% | 4.10 M USD |
Frequently asked questions about Vivos Therapeutics, Inc. Common Stock
What is the Vivos Therapeutics, Inc. Common Stock stock price today?
The current price of Vivos Therapeutics, Inc. Common Stock (VVOS) is 0.26. Over the past 24 hours, the stock has changed by +4.00%. Follow the VVOS chart for real-time price dynamics.
What is the stock ticker of Vivos Therapeutics, Inc. Common Stock?
Vivos Therapeutics, Inc. Common Stock trades under the ticker VVOS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Vivos Therapeutics, Inc. Common Stock stock going up?
VVOS has changed by -10.34% over the last week, -40.91% over the last month, and -94.47% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Vivos Therapeutics, Inc. Common Stock?
Vivos Therapeutics, Inc. Common Stock currently has a market capitalization of 5.23 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Vivos Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Vivos Therapeutics, Inc. Common Stock reported earnings of -0.31 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Vivos Therapeutics, Inc. Common Stock revenue for the last quarter?
Vivos Therapeutics, Inc. Common Stock reported quarterly revenue of 5.15 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Vivos Therapeutics, Inc. Common Stock net income for the last quarter?
Vivos Therapeutics, Inc. Common Stock reported net income of -5.48 M for the last quarter. The previous quarter showed -7.68 M, which means net income changed by +28.65%.
How many employees does Vivos Therapeutics, Inc. Common Stock have?
As of the latest available data, Vivos Therapeutics, Inc. Common Stock has 268 employees. Workforce size can provide additional context about the company's scale and operations.
What is Vivos Therapeutics, Inc. Common Stock EBITDA?
Vivos Therapeutics, Inc. Common Stock EBITDA is -4.33 M, and its EBITDA margin is -83.93%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Vivos Therapeutics, Inc. Common Stock stock?
You can buy Vivos Therapeutics, Inc. Common Stock (VVOS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Vivos Therapeutics, Inc. Common Stock stock?
Investing in Vivos Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VVOS chart and related analysis on metatrader.com as part of your research.